Table 2 The Clinical characteristics and medication use of hospitalized heart failure patients at MRRH, Southwestern Uganda from November 2021 to January 2022
Variables | Categories | N (%) |
|---|---|---|
Duration of the HF | New | 56 (47.5) |
Known | 59 (52.5) | |
Previous hospital admission | 78 (66.1) | |
Length of hospital stay (days) Median (IQR): 8 (6–10) | ≤5 | 27 (22.9) |
6–10 | 59 (50) | |
≥11 | 32 (27.1) | |
Comorbidity | 93 (78.8) | |
Number of comorbidities (N = 93) | One (1) | 56 (60.2) |
Two (2) and above | 37 (39.8) | |
Counseling on medication use | 107 (90.7) | |
OTC use within the past 4 weeks | 42 (35.6) | |
Herbal use within the past 4 weeks | 52 (44.1) | |
Poly-pharmacy | 75 (63.5) | |
Significant drug-drug interaction | 79 (66.9) | |
Treatment affordability | 18 (15.3) | |